前向传导通过TBX18生物起搏挽救右室起搏诱导的心肌病
在猪完全性房室传导阻滞模型中,将表达TBX18的腺病毒载体注射至希氏束区域,可预防和逆转右室起搏诱导的心肌病(PICM)。预防方案中TBX18组心率、后备起搏使用率和射血分数均优于对照组;逆转方案中已形成PICM后注射TBX18仍能改善上述指标。
要点
- TBX18生物起搏可预防右室起搏诱导的心肌病。
- 已形成的PICM在TBX18干预后也可部分逆转。
- TBX18组心率更高、后备起搏依赖更少、射血分数更优。
核心结论
- 在临床前猪模型中,通过TBX18生物起搏恢复前向传导可预防并逆转起搏器诱导的心肌病。
研究设计与样本
- 研究在猪完全性房室传导阻滞模型中开展,方案A在房室结消融后注射表达TBX18的腺病毒载体或绿色荧光蛋白对照,观察8周以评估预防PICM。
- 方案B先通过房室结消融和4周电子右室起搏建立PICM,再向希氏束区域注射TBX18,以评估逆转PICM。
主要发现
- 方案A中,TBX18组心率(62.4 ± 3 次/分 vs. 50.4 ± 0.4 次/分;p = 0.01)、后备起搏使用率(45 ± 2.6% vs. 94.6 ± 1.4%;p = 0.001)和射血分数(58.5 ± 1.3% vs. 46.7 ± 2%;p = 0.001)均优于对照组。
- 方案B中,两组在完全性房室传导阻滞后4周均出现明显PICM;后续干预后,TBX18组平均心率(56 ± 2 次/分 vs. 50.1 ± 0.4 次/分;p = 0.05)、后备起搏使用率(53 ± 8.2% vs. 95 ± 1.6%;p = 0.003)和射血分数(61.7 ± 1.3% vs. 49 ± 1.6%;p = 0.0003)均优于对照组。
临床怎么用
- 在完全性房室传导阻滞需右室起搏的患者中,TBX18生物起搏策略可能提供前向传导以预防PICM,但尚处于临床前阶段。
- 对于已发生PICM的患者,恢复前向传导可能作为逆转心肌病的潜在手段,需进一步临床验证。
局限性
- 研究为猪临床前模型,结果不能直接推广至人类。
- 样本量未在摘要中报告,长期安全性和有效性未知。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Right ventricular (RV) pacing-induced cardiomyopathy (PICM) occurs in ∼30% of patients with RV leads. This study evaluated the long-term effects of restoring antegrade conduction with a biological pacemaker in a porcine model of RV PICM. OBJECTIVES: The goal of this study was to determine if antegrade biological pacing can attenuate RV PICM. METHODS: In pigs with complete atrioventricular (AV) block, transcription factor T-box 18 (TBX18) was injected into the His bundle region in either of 2 experimental protocols: protocol A sought to prevent PICM, and protocol B sought to reverse PICM. In protocol A, we injected adenoviral vectors expressing TBX18 (or the reporter construct green fluorescent protein) after AV node ablation, and observed the animals for 8 weeks. In protocol B, PICM was established by using AV node ablation and 4 weeks of electronic RV pacing, at which point TBX18 was injected into the His bundle region. RESULTS: In protocol A, TBX18 biological pacing led to superior chronotropic support (62.4 ± 3 beats/min vs. 50.4 ± 0.4 beats/min; p = 0.01), lower backup pacemaker utilization (45 ± 2.6% vs. 94.6 ± 1.4%; p = 0.001), and greater ejection fraction (58.5 ± 1.3% vs. 46.7 ± 2%; p = 0.001). In protocol B, full-blown RV PICM was evident 4 weeks after complete AV block in both groups; subsequent intervention led to higher mean heart rate (56 ± 2 beats/min vs. 50.1 ± 0.4 beats/min; p = 0.05), less backup pacemaker utilization (53 ± 8.2% vs. 95 ± 1.6%; p = 0.003), and a greater ejection fraction (61.7 ± 1.3% vs. 49 ± 1.6%; p = 0.0003) in TBX18-injected animals versus control animals. CONCLUSIONS: In a preclinical model, pacemaker-induced cardiomyopathy can be prevented, and reversed, by restoring antegrade conduction with TBX18 biological pacing.
引用
- Dawkins JF, Hu YF, Valle J, et al. Antegrade Conduction Rescues Right Ventricular Pacing-Induced Cardiomyopathy in Complete Heart Block. J Am Coll Cardiol. 2019. PMID: 30947921. doi:10.1016/j.jacc.2018.12.086
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。